Post-Translational Inactivation of Endothelial Nitric Oxide Synthase in the Transgenic Sickle Cell Mouse Penis

Authors

  • Biljana Musicki PhD,

    Corresponding author
    1. The Johns Hopkins University, Department of Urology, Baltimore, MD, USA
      Biljana Musicki, PhD, The Johns Hopkins University, Department of Urology, Baltimore, MD 21287, USA. Tel: (410) 955-0352; Fax: (410) 614-3695; E-mail: bmusicki@jhmi.edu
    Search for more papers by this author
  • Hunter C. Champion MD, PhD,

    1. Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Search for more papers by this author
  • Lewis L. Hsu MD, PhD,

    1. Vascular Medicine Branch, National Heart Lung Blood Institute, National Institutes of Health, Bethesda, MD, USA
    2. Hematology Division, Children's National Medical Center, Washington, DC, USA
    Search for more papers by this author
  • Trinity J. Bivalacqua MD, PhD,

    1. The Johns Hopkins University, Department of Urology, Baltimore, MD, USA
    Search for more papers by this author
  • Arthur L. Burnett MD

    1. The Johns Hopkins University, Department of Urology, Baltimore, MD, USA
    Search for more papers by this author

Biljana Musicki, PhD, The Johns Hopkins University, Department of Urology, Baltimore, MD 21287, USA. Tel: (410) 955-0352; Fax: (410) 614-3695; E-mail: bmusicki@jhmi.edu

ABSTRACT

Introduction.  Sickle cell disease (SCD)-associated priapism is characterized by endothelial nitric oxide synthase (eNOS) dysfunction in the penis. However, the mechanism of decreased eNOS function/activation in the penis in association with SCD is not known.

Aims.  Our hypothesis in the present study was that eNOS is functionally inactivated in the SCD penis in association with impairments in eNOS post-translational phosphorylation and the enzyme's interactions with its regulatory proteins.

Methods.  Sickle cell transgenic (sickle) mice were used as an animal model of SCD. Wild-type (WT) mice served as controls. Penes were excised at baseline for molecular studies. eNOS phosphorylation on Ser-1177 (positive regulatory site) and Thr-495 (negative regulatory site), total eNOS, and phosphorylated AKT (upstream mediator of eNOS phosphorylation on Ser-1177) expressions, and eNOS interactions with heat-shock protein 90 (HSP90) and caveolin-1 were measured by Western blot. Constitutive NOS catalytic activity was measured by conversion of L-[14C]arginine-to-L-[14C]citrulline in the presence of calcium.

Main Outcome Measures.  Molecular mechanisms of eNOS dysfunction in the sickle mouse penis.

Results.  eNOS phosphorylated on Ser-1177, an active portion of eNOS, was decreased in the sickle mouse penis compared with WT penis. eNOS interaction with its positive protein regulator HSP90, but not with its negative protein regulator caveolin-1, and phosphorylated AKT expression, as well as constitutive NOS activity, were also decreased in the sickle mouse penis compared with WT penis. eNOS phosphorylated on Thr-495, total eNOS, HSP90, and caveolin-1 protein expressions in the penis were not affected by SCD.

Conclusions.  These findings provide a molecular basis for chronically reduced eNOS function in the penis by SCD, which involves decreased eNOS phosphorylation on Ser-1177 and decreased eNOS-HSP90 interaction. Musicki B, Champion HC, Hsu LL, Bivalacqua TJ, and Burnett AL. Post-translational inactivation of endothelial nitric oxide synthase in the transgenic sickle cell mouse penis. J Sex Med 2011;8:419–426.

Ancillary